Advancing CRISPR Genome Editing Tools to Accelerate Clinical Translation
- Expanding CRISPR editing and delivery capabilities, with broader genomic reach, to unlock treatments for previously undruggable diseases
- Accelerating target discovery and CRISPR therapy optimization using in vitro technologies, robotics, automation, and AI to compress development timelines
- Navigating emerging regulatory pathways, designed specifically for gene therapies, to bring CRISPR treatments to human trials faster